Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 studyDo‐Youn Oh, Juan W. Valle, Masayuki Kitano et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 245
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M. Huffman, Samuel J. Klempner, Vasily N. Aushev et al.|JCO Precision Oncology|2022Cited by 72
Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphomaFarshid Dayyani, Gerold Meinhardt|Journal of Leukocyte Biology|2003Cited by 18